NCT01987570View on ClinicalTrials.gov

Effect of Allopurinol Administration on the Prevention of Muscle Mass Loss in Subject Immobilized.

PHASE3CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Patients With Grade II Ankle Sprain
Interventions
DRUG

Allopurinol

DRUG

Placebo

Trial Locations (2)

46010

University of Valencia, Valencia

46026

Hospital Universitari i Politècnic La Fe, Valencia

All Listed Sponsors
lead

Instituto de Investigacion Sanitaria La Fe

OTHER

NCT01987570 - Effect of Allopurinol Administration on the Prevention of Muscle Mass Loss in Subject Immobilized. | Biotech Hunter | Biotech Hunter